Aptose Biosciences, Inc. Rings the Closing Bell
ABOUT THIS EVENT
Aptose Biosciences Inc. (Nasdaq: APTO), a clinical-stage company with two highly differentiated therapeutics targeting hematological malignancies including leukemias and lymphomas, rings the Nasdaq Closing Bell remotely from across the country.
In celebration of its 6th Listing Anniversary, William G. Rice, Ph.D., Chairman, President & CEO, rings the Closing Bell alongside some of the Company’s employees and board members in a virtual bell ringing ceremony.